Pseudomonas vaccine
Latest Information Update: 16 Jul 2016
At a glance
- Originator Louisiana State University; Nonindustrial source; Russian Academy of Medical Sciences
- Developer Louisiana State University; Russian Academy of Medical Sciences
- Class Bacterial vaccines; Pseudomonas vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pseudomonal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pseudomonal-infections in USA (Parenteral)
- 26 Apr 1999 A preclinical study has been added to the Bacterial Infections pharmacodynamics section
- 18 Nov 1996 Preclinical development for Pseudomonal infections in USA (Parenteral)